News
Sanofi's Rilzabrutinib LUNA 3 Phase 3 Study Met Primary Endpoint In Immune Thrombocytopenia
23 Apr 24
News
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
21 Apr 24
Analyst Color, Equities, News, Top Stories, Tech, Trading Ideas
Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick
17 Apr 24
Analyst Color, Biotech, Equities, Large Cap, News, Health Care, Reiteration, Analyst Ratings, Trading Ideas, General
Novartis Multiple Sclerosis Drug Kesimpta Shows Substantial Benefit Of Up To 6 Years
17 Apr 24
Biotech, Large Cap, News, Health Care, General
Sanofi's Multiple Sclerosis Antibody Shows Reduction Of Disease Activity
17 Apr 24
Biotech, Large Cap, News, Health Care, General
Sanofi's CD40L Antibody: New 48-Week Phase 2 Data Support Frexalimab's Potential For High Sustained Efficacy In Multiple Sclerosis
17 Apr 24
News
Novo Nordisk/Eli Lilly's Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says
12 Apr 24
Biotech, Large Cap, News, Health Care, Top Stories, Movers, General
Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says
10 Apr 24
Analyst Color, Biotech, Equities, Large Cap, News, Health Care, Price Target, Reiteration, Analyst Ratings, Trading Ideas, General
Nurix Therapeutics Extends Ongoing Research Program With Sanofi For STAT6; Anticipates Nominating A Clinical Candidate Within The First Year Of Extension
9 Apr 24
News
In Heart Burn Drug Zantac's Litigation Saga, Sanofi Nears Settlement in Major Lawsuit Cluster
4 Apr 24
Biotech, Large Cap, News, Health Care, Legal, General
'Sanofi Agrees To Settle About 5,000 Zantac Cancer Suits In US' - Bloomberg
3 Apr 24
News, Legal
What's Going On European Pharma Giant AstraZeneca Stock On Wednesday?
27 Mar 24
Biotech, Large Cap, News, Health Care, Movers, Trading Ideas, General
How Is The Market Feeling About Sanofi?
27 Mar 24
Short Sellers, Short Ideas, Trading Ideas
Krispy Kreme-McDonald's Deal Spikes Insulin Stock Interest: 'We're About To Cash In On The Aftermath'
26 Mar 24
Long Ideas, Health Care, Restaurants, Top Stories, Movers, Trading Ideas, General
'PE Firms Eye €7.5 Billion Leveraged Financing For Sanofi Unit; Consumer-Health Unit Could Be One Of Biggest Recent LBOs; CD&R Among Private Equity Firms Looking At Consumer Unit' - Bloomberg News
15 Mar 24
News, Asset Sales
Sanofi Says Results From Part 2 Of Amlitelimab Phase 2B Study STREAM-AD Showed Sustained Improvement Of Signs And Symptoms For 28 Weeks In Adults With Moderate To Severe Atopic Dermatitis
11 Mar 24
Biotech, Large Cap, News, Health Care, General
(SNY) - Analyzing Sanofi's Short Interest
8 Mar 24
Short Sellers, Short Ideas, Trading Ideas
11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
28 Feb 24
Equities, Eurozone, Top Stories, Markets, ETFs
Reported Saturday, Sanofi's Rilzabrutinib Phase 2 Results Demonstrate Rapidly Reduced Itch Severity And Significantly Improved Disease Activity In Adults With Chronic Spontaneous Urticaria
26 Feb 24
News
Regeneron Pharmaceuticals And Sanofi Announce That Dupixent® sBLA Has Been Accepted For FDA Priority Review For Treatment of COPD With Type 2 Inflammation
23 Feb 24
News
Press releases
INHIBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inhibrx, Inc. - INBX
10 Feb 24
Press Releases
CytoReason's AI-Driven Disease Model Platform Trusted By 5 Top 10 Pharma Companies Harnesses Big Data To Speed Drug Discovery And Development
6 Feb 24